|
"liou bh"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2021 |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang, YS; Cheng, CY; Liou, BH; Lu, PL; Cheng, SH; Lee, YT; Liu, CE; Sun, HY; Yang, CJ; Tang, HJ; Lin, SP; Ho, MW; Huang, SH; Tsai, HC; Lee, CH; Hung, CC |
| 中山醫學大學 |
2021 |
Screening and short-course treatment for latent tuberculosis infection among people living with HIV who received integrase inhibitor-based antiretroviral therapy
|
Lin, KY; Yang, CJ; Sun, HY; Lee, YT; Liou, BH; Hii, IM; Chen, TC; Huang, SH; Lee, CY; Tsai, CS; Lin, CY; Liu, CE; Chang, HY; Cheng, CY; Lu, PL; Hung, CC |
| 中山醫學大學 |
2021 |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee, YL; Lin, KY; Cheng, SH; Lu, PL; Wang, NC; Ho, MW; Yang, CJ; Liou, BH; Tang, HJ; Huang, SS; Huang, SH; Chen, TC; Lin, CY; Lin, SP; Lee, YT; Hung, CC |
| 國家衛生研究院 |
2016-06 |
Risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial Acinetobacter nosocomialis bacteremia
|
Lai, HH;Liou, BH;Chang, YY;Kuo, SC;Lee, YT;Chen, TL;Fung, CP |
| 國家衛生研究院 |
2015-06 |
Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure
|
Liou, BH;Lee, YT;Kuo, SC;Liu, PY;Fung, CP |
| 國家衛生研究院 |
2014-10 |
A multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan
|
Liou, BH;Duh, RW;Lin, YT;Yang, LTL;Fung, CP;Taiwan Surveillance of Antimicrobial Resistance (TSAR) Hospitals |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
